Autonomy Health
PrivateCompany Overview
Autonomy Health is a healthcare technology company that provides a neurology-focused management services organization (MSO) platform to help independent practices streamline operations and improve patient care.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Revenue Cycle, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
management services organizationMSOrevenue cycle managementRCMpractice management softwareprior authorization automationworkflow automationneurology practice managementmedical billing servicesreferral managementpractice operationsvertical SaaSmedical practice supporthealth techphysician enablement
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autonomy Health Comparables
Compare Autonomy Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| U.S. Neurology Associates | 88% | |
| Nira Medical | 84% | |
| CardioOne | 72% | |
Autonomy Health Funding Rounds
Historical fundraising activity
Autonomy Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autonomy Health's valuation, stock price, and market status.
Firmographic Details
HeadquartersNew York City, New York
Employee Range1
Year Founded2025
Last Funding—